Q32 Bio Inc. – Material Contracts Watch

EX-10.2

from 8-K 19 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 40 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 51 pages Q32 Bio Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-10.32

from 10-K 77 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Asset Purchase Agreement Between Q32 Bio Inc. and Q32 Bio Operations Inc. and Akebia Therapeutics, Inc. Dated as of November 28, 2025

12/34/56

EX-10.1

from 8-K 31 pages Securities Purchase Agreement

12/34/56

EX-10.18

from 8-K 16 pages Employment Agreement

12/34/56

EX-10.17

from 8-K 16 pages Employment Agreement

12/34/56

EX-10.16

from 8-K 16 pages Employment Agreement

12/34/56

EX-10.15

from 8-K 16 pages Employment Agreement

12/34/56

EX-10.14

from 8-K 13 pages Warrant to Purchase Stock

12/34/56

EX-10.13

from 8-K 13 pages Warrant to Purchase Stock

12/34/56

EX-10.12

from 8-K 3 pages Q32 Bio Inc. Senior Executive Cash Incentive Bonus Plan

12/34/56

EX-10.11

from 8-K 3 pages Q32 Bio Inc. Non-Employee Director Compensation Policy

12/34/56

EX-10.10

from 8-K 9 pages Q32 Bio Inc. 2024 Employee Stock Purchase Plan

12/34/56

EX-10.9

from 8-K 49 pages Q32 Bio Inc. 2024 Stock Option and Incentive Plan

12/34/56

EX-10.8

from 8-K 48 pages Admirx Inc. 2017 Stock Option and Grant Plan

12/34/56

EX-10.7

from 8-K 17 pages Q32 Bio Inc. Amended and Restated Form of Director Indemnification Agreement

12/34/56

EX-10.6

from 8-K 17 pages Q32 Bio Inc. Amended and Restated Form of Officer Indemnification Agreement

12/34/56

EX-10.4

from 8-K 26 pages Contingent Value Rights Agreement

12/34/56

EX-10.3

from 8-K 7 pages Lock-Up Agreement

12/34/56